Three scientists from Pune medical college feature in Stanford’s top 2% scientists list

Dr. Amitav Banerjee has a distinguished research career spanning over four decades. His substantial body of work encompasses critical investigations into epidemics, including typhoid, hepatitis, respiratory infections, and pneumonia.

Many of these pivotal studies were conducted during his tenure with the Indian Armed Forces.  Dr. Banerjee’s research excellence in epidemiology, especially in the fields of tribal malaria and viral hepatitis, has earned him prestigious awards and recognition.

Presently, he serves as the editor of the International Medical Journal of DR. D.Y. Patil Vidyapeeth, Pune.

“Successful research demands unwavering patience, dedication, and perseverance. The true measure of research excellence lies in the recognition and citation of one’s work by fellow scholars.. The number of outbreaks I have contributed to investigating is a rare privilege,” he said.

Dr Sarika Chaturvedi, holds a PhD from the prestigious Karolinska Institute in Sweden and her endeavors are primarily concentrated on public health and traditional medicine.  Majority of her highly cited work stems from her diligent contributions to the public healthcare system, focusing on the assessment of disease burdens and estimates of disease risk factors.

According to Dr Chaturvedi, funding support is crucial, and so is the responsible association of reviewers, peers and mentors. “To me, the essence of meaningful research lies in creating positive changes within communities and ensuring their well-being,” she said.

Dr Sachin Atre, a medical anthropologist with over two decades of research experience in public health, has also earned a place in the esteemed Stanford list. Dr. Atre received his Ph.D. from the University of Pune and was honored with the prestigious Fulbright-Nehru Postdoc Fellowship at Harvard Medical School in the USA. His significant contributions span research on tuberculosis and drug-resistant tuberculosis, as well as nutrition, diabetes, leprosy, and access to medicines.